We are live on ! Find out more
ROIV icon

Roivant Sciences
ROIV

181 hedge funds and large institutions have $5.02B invested in Roivant Sciences in 2023 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 58 increasing their positions, 46 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

483% more call options, than puts

Call options by funds: $8.47M | Put options by funds: $1.45M

152% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 23

48% more capital invested

Capital invested by funds: $3.39B → $5.02B (+$1.63B)

26% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 46

23% more funds holding

Funds holding: 147 → 181 (+34)

4.33% more ownership

Funds ownership: 60.57% → 64.9% (+4.3%)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

Holders
181
Holders Change
+34
Holders Change %
+23.13%
% of All Funds
2.84%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
58
Increased
58
Reduced
46
Closed
23
Calls
$8.47M
Puts
$1.45M
Net Calls
+$7.02M
Net Calls Change
+$3.44M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$87.8M
2
BlackRock
BlackRock
New York
+$55.2M
3
PSC
Patient Square Capital
California
+$52M
4
ACA
Avoro Capital Advisors
New York
+$51.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.8M

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$116M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$33.9M
3
RCMNY
Rubric Capital Management (New York)
New York
-$18.5M
4
Goldman Sachs
Goldman Sachs
New York
-$15M
5
Citadel Advisors
Citadel Advisors
Florida
-$12.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$18.3M +$39.4K +4,407 +0.2%
LCM
27
Laurion Capital Management
New York
$17.2M +$5.9M +660,041 +63%
Millennium Management
28
Millennium Management
New York
$17.1M +$11.5M +1,287,479 +315%
EAM
29
Eventide Asset Management
Massachusetts
$17M – – –
APM
30
Avidity Partners Management
Texas
$17M +$15.1M +1,687,500 New
Franklin Resources
31
Franklin Resources
California
$16.4M +$36 +4 +0%
AG
32
Artal Group
Luxembourg
$16.4M +$9.17M +1,025,000 +171%
RI
33
RTW Investments
New York
$15.7M – – –
Marshall Wace
34
Marshall Wace
United Kingdom
$14M +$9.78M +1,093,255 +365%
DM
35
Deerfield Management
New York
$13.7M -$3.53M -395,026 -23%
Invesco
36
Invesco
Georgia
$13.4M +$5.32M +594,416 +81%
DKCM
37
Davidson Kempner Capital Management
New York
$13.1M +$11.6M +1,300,000 New
Victory Capital Management
38
Victory Capital Management
Texas
$12M +$10.6M +1,190,081 New
FFVM
39
Founders Fund VI Management
California
$11.3M – – –
Two Sigma Investments
40
Two Sigma Investments
New York
$10.6M -$1.51M -168,681 -14%
Bank of America
41
Bank of America
North Carolina
$10.4M -$11.4K -1,273 -0.1%
Voloridge Investment Management
42
Voloridge Investment Management
Florida
$9.15M -$805K -90,020 -9%
Northern Trust
43
Northern Trust
Illinois
$8.91M +$4.07M +455,564 +106%
AGP
44
Artia Global Partners
Florida
$8.31M +$5.96M +666,600 +423%
Rafferty Asset Management
45
Rafferty Asset Management
New York
$7.99M -$502K -56,075 -7%
PIM
46
Platinum Investment Management
Australia
$7.65M +$1.22M +135,997 +22%
Swiss National Bank
47
Swiss National Bank
Switzerland
$7.49M +$1.04M +116,800 +19%
N
48
Nuveen
North Carolina
$7.42M +$6.59M +736,589 New
Bank of New York Mellon
49
Bank of New York Mellon
New York
$7.13M +$5.08M +568,197 +409%
HF
50
HRT Financial
New York
$6.41M +$5.68M +635,470 New
1
2
3 4 5

ROIV Hedge Fund Activity: Q2 2023 in Review

181 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q2 2023, worth a combined $5.02B — up 48% from $3.39B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ROIV positions and 23 closed out — a net gain of 35 holders — while 58 added to existing stakes and 46 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $87.8M. The largest seller was Viking Global Investors, cutting an estimated $116M.

  • 181 institutional investors held Roivant Sciences (ROIV) as of Q2 2023, up from 147 in Q1 2023.
  • Funds reported $5.02B of Roivant Sciences stock for Q2 2023, up 48% quarter-over-quarter.
  • 58 funds opened new Roivant Sciences positions in Q2 2023 and 23 closed out, a net change of +35 holders.
  • The largest Roivant Sciences buyer in Q2 2023 was Morgan Stanley, an estimated $87.8M added.
  • The largest Roivant Sciences seller in Q2 2023 was Viking Global Investors, an estimated $116M sold.

Based on aggregated 13F filings for Q2 2023.